Erzofri
Active Ingredient(s): Paliperidone PalmitateFDA Approved: * July 26, 2024
Pharm Company: * LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD.
Category: Antipsychotic
Paliperidone, sold under the trade name Invega among others, is an atypical antipsychotic. It is mainly used to treat schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals. An extended release formulation is available that uses the OROS extended release system to allow for once-daily dosing. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester. It is on the World Health Organization's List of Essential Medicines.... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.